Pekka MattilaCEO, Desentum
Pekka co-founded Desentum in 2011 and has acted as the chief executive officer since then. Pekka has an extensive experience of managing biotech companies. Prior to founding Desentum, he was the co-founder of a Finnish biotech company Finnzymes Ltd and acted as its CEO for 25 years until 2010, when the company was acquired by Thermo Fisher Scientific.
Pekka is currently a board member in several biotech and pharmaceutical companies including Herantis Pharma Plc, Fimmic Oy, Medix Biochemica Oy and Mobidiag Oy.
Pekka holds a M.Sc. degree from Helsinki University of Technology in biochemistry, biotechnology and microbiology.